Literature DB >> 28409755

Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.

M Kaneko, M Sato, K Ogasawara, T Imamura, K Hashimoto, N Momoi, M Hosoya.   

Abstract

OBJECTIVE: To investigate the relationships between serum cytokine concentrations and chorioamnionitis (CAM) and CAM-related bronchopulmonary dysplasia (BPD) in premature infants.
METHODS: Serum was collected at 0 and 7 days after birth from 36 premature infants born at <32 weeks of gestation. We examined the relationships between 30 cytokine concentrations and CAM, BPD, and other perinatal factors.
RESULTS: On day 0, GM-CSF, IL-15, IL-17, IL-2, IL-2R, VEGF, and MIG concentrations were significantly higher in the CAM group (n = 17) than in the non-CAM group (n = 19). These concentrations had decreased by day 7 and were similar in both groups. The IL-12p70 concentration on day 0 was significantly lower in the BPD group (n = 16) than in the non-BPD group (n = 15). BPD incidence was similar between the CAM and non-CAM groups.
CONCLUSIONS: These data support the hypothesis that intrauterine inflammation is not a primary risk factor for BPD. The immunological environment at birth or soon after, rather than intrauterine fetal inflammation (e.g., CAM), is a primary risk factor for BPD onset in preterm infants. Decreased inflammatory responses are particularly relevant, as indicated by the relationship between BPD and low serum IL-12p70 concentrations on day 0.

Entities:  

Keywords:  Cytokines; inflammation; interleukin-12; neonatal prematurity

Mesh:

Substances:

Year:  2017        PMID: 28409755     DOI: 10.3233/NPM-171669

Source DB:  PubMed          Journal:  J Neonatal Perinatal Med        ISSN: 1878-4429


  3 in total

1.  Efficacy of budesonide in the prevention and treatment of bronchopulmonary dysplasia in premature infants and its effect on pulmonary function.

Authors:  Yanli Yao; Guofei Zhang; Fei Wang; Meili Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Long non-coding RNA Rian protects against experimental bronchopulmonary dysplasia by sponging miR-421.

Authors:  Xifeng Tao; Yafei Fang; Chen Huo
Journal:  Exp Ther Med       Date:  2021-05-19       Impact factor: 2.447

3.  Can biomarkers be used to predict bronchopulmonary dysplasia?

Authors:  Vineet Bhandari; Mitali Sahni
Journal:  J Pediatr (Rio J)       Date:  2020-10-23       Impact factor: 2.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.